Shares of Silence Therapeutics SLN plunged 36.8% on Tuesday despite reporting positive end-of-treatment data from a mid-stage study of lead candidate, zerlasiran, to treat atherosclerotic ...
The usefulness of sentinel lymph node (SLN) biopsy was investigated among patients with melanoma and SLN metastases. Known to be effective for staging cutaneous melanoma, sentinel lymph node (SLN) ...
A recent study said superior laryngeal nerve (SLN) blocks are effective for treating neurogenic cough, which are coughs that continue and persist after other conditions are ruled out. A new study ...
We recently published a list of 10 Most Promising Gene Editing Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Silence Therapeutics plc (NASDAQ:SLN) ...
SLN is trading near the bottom of its 52-week range and near its 200-day simple moving average. Price change The price of SLN shares has decreased $0.20 since the market last closed. This is a 3.85% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback